Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Anti Kickback
The EpiPen Whistleblower Saga Comes to a Close
Last week, Mylan Inc. and Mylan Specialty L.P. (hereinafter “Mylan”) reached an agreement with the United States Department of…
Celgene Settles Cancer Drug Whistleblower Suit
Celgene Corporation has settled a whistleblower lawsuit for $280 million, alleging that the pharmaceutical company committed fraud…
LSCU SPECIAL FEATURE: Into the Nexus – Anti-Kickback Statute…
Part 2: The Tension Increases - Online Auctions Violate the AKS
We have noted in previous articles that there is an increasing…
LSCU SPECIAL FEATURE: Into the Nexus – Anti-Kickback Statute…
Part 1: An Uncertain Future in a Dynamic Landscape
Fans of Star Trek will remember the scene from the 1994 movie “Generations”…
California Gift Ban Bill to be Heard Tomorrow
On Tuesday, June 27, 2017, California Senate Bill 790 will be heard in the Assembly Committee on Health, with limited testimony…
A Port in Any Storm – Adding New Safe Harbors to the Anti-Kickback Statute
On December 7, 2016, the HHS Office of the Inspector General ("OIG") approved new safe harbors to the federal anti-kickback…
Quest to Pay $6 Million to Settle Kickback and Unnecessary Testing…
On April 28, 2017, the United States Department of Justice announced a settlement with Quest Diagnostics, Inc., for $6 million to…
Novo Nordisk Settles Qui Tam Suit
Novo Nordisk is in the midst of settling a whistleblower lawsuit that alleges that the company ran a “white-coat marketing scheme”…
The New Strict French Anti-Bribery Law
In early December 2016, the Sapin II law was enacted in France. The law, which is meant to promote transparency, fight against…
Healthcare Providers Accused of $100 Million Kickback Scheme
A dozen doctors, pharmacy owners, and marketing professionals have been accused of being involved in a sham medical…